Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lantheus Holdings Logo
Lantheus Holdings Growth Score
86
CB Rank
203271
Heat Score
19
Lantheus Holdings is a radiopharmaceutical company that develops, manufactures, and commercializes diagnostic and therapeutic products.
Founded
obfuscation
Public North Billerica, Massachusetts, United States501-1000 www.lantheus.com/
Health Diagnostics
Manufacturing
Medical
Overview

Lantheus Holdings
Growth Score
86
Heat Score
19

Growth Score86
2 pts
in past quarter
Heat Score 19
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Lantheus Holdings

CB Rank
203271
Lantheus Holdings is a radiopharmaceutical company that develops, manufactures, and commercializes diagnostic and therapeutic products.
Founded
obfuscation
Public North Billerica, Massachusetts, United States501-1000 www.lantheus.com/
Health Diagnostics
Manufacturing
Medical

Key People

  • Photo of Robert Marshall
    Robert Marshall: Chief Financial Officer and Treasurer
    Past Role: Zimmer Biomet, Vice President of Americas Finance
  • Photo of Jamie Spaeth
    Jamie Spaeth: Chief People Officer
    Past Role: Corium, Chief People Officer

Details

Legal Name Lantheus Holdings Inc
Operating Status Active
Number of Exits 
obfuscation
Stock Symbol  NASDAQ:LNTH
Company Type For Profit
About the Company
Lantheus Medical Imaging, a global leader in developing, manufacturing, selling, and distributing innovative diagnostic imaging agents, is dedicated to creating and providing medical imaging solutions to improve the treatment of human disease.
Phone Number +1 978-671-8001
Contact Email info@lantheus.com
Predictions & Insights

Growth Insight

See this Growth Insight
Lantheus Holdings is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Radiopharmaceutical Oncology Products
Radiopharmaceutical agents used for the diagnosis and treatment of cancer, enabling clinicians to detect, target, and monitor cancer progression.
Precision Diagnostics
Diagnostic radiopharmaceutical agents that help detect and monitor diseases in early stages, particularly non-oncologic conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Investments

Number of Investments 2
Number of Exits 
obfuscation
Number of Acquisitions 5
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation

Investment Breakdown

Number of Investments 2
Number of Exits 
obfuscation
Number of Acquisitions 5
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
obfuscation
RadioPharm Theranostics Logo
RadioPharm Theranostics
Yes
Post-IPO Equity - RadioPharm Theranostics Logo
Post-IPO Equity - RadioPharm Theranostics
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 501-1000 Employee Profiles 6 Contacts 895

Employee Profiles

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

26,279
40.51%
 in past month

IT Spend

$33MThis year, Lantheus Holdings is projected to spend $33M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Benefits Administration Logo
Benefits Administration
100
Password Vault Logo
Password Vault
100
Employer of Record (EOR) Logo
Employer of Record (EOR)
100

Actively Used Products

16Lantheus Holdings uses 16 technology products and services including HTML5, Google Compute Engine, and  Wordpress, according to G2 Stack.

Active Website Tech Count

44Lantheus Holdings is actively using 44 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  HSTS.

Total IP

136The intellectual property of Lantheus Holdings includes 84 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Lantheus Holdings has registered 52 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Lantheus - SPECT Business Logo
Lantheus - SPECT BusinessSubsidiary
Frequently Asked Questions

Where is Lantheus Holdings's headquarters? Lantheus Holdings is located in North Billerica, Massachusetts, United States.Who are Lantheus Holdings's competitors? Alternatives and possible competitors to Lantheus Holdings may include GE Healthcare, Nusano, and  Medi-Radiopharma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|